Semi-Annual Consolidated Statement Of Cash Flows

Kohjin Bio Co., Ltd. - Filing #7296611

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
366,794,000 JPY
Depreciation
175,584,000 JPY
Increase (decrease) in allowance for doubtful accounts
-24,714,000 JPY
Interest and dividend income
-609,000 JPY
Interest expenses
14,325,000 JPY
Increase (decrease) in retirement benefit liability
1,026,000 JPY
Share of loss (profit) of entities accounted for using equity method
-55,988,000 JPY
Increase (decrease) in provision for bonuses
15,678,000 JPY
Decrease (increase) in trade receivables
74,786,000 JPY
Decrease (increase) in inventories
8,954,000 JPY
Increase (decrease) in trade payables
-22,961,000 JPY
Other, net
35,928,000 JPY
Subtotal
572,592,000 JPY
Interest and dividends received
542,000 JPY
Interest paid
-14,607,000 JPY
Income taxes paid
-40,382,000 JPY
Net cash provided by (used in) operating activities
518,146,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-458,102,000 JPY
Proceeds from sale of property, plant and equipment
2,401,000 JPY
Net cash provided by (used in) investing activities
-466,696,000 JPY
Cash flows from financing activities
Proceeds from short-term borrowings
500,000,000 JPY
Repayments of short-term borrowings
-500,000,000 JPY
Repayments of long-term borrowings
-75,000,000 JPY
Proceeds from issuance of shares
1,653,044,000 JPY
Dividends paid
-58,310,000 JPY
Net cash provided by (used in) financing activities
1,485,818,000 JPY
Other, net
-6,620,000 JPY
Effect of exchange rate change on cash and cash equivalents
42,575,000 JPY
Net increase (decrease) in cash and cash equivalents
1,579,843,000 JPY
Cash and cash equivalents
3,306,780,000 JPY
1,726,936,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.